跳至主要内容
临床试验/NCT00973869
NCT00973869Unknown1 期

A Pilot Study of Administration of Curcumin to Determine Colonic Curcumin Tissue Levels in Patients Awaiting Colorectal Endoscopy or Patients With Colorectal Cancer Awaiting Resection

University of Leicester4 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2009年7月最近更新:
适应症

试验速览

阶段
1 期
入组人数
30
试验地点
4
主要终点
Concentration of curcumin in colorectal tissue after treatment

研究概览

简要总结

RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming. The use of curcumin may prevent or treat colorectal cancer.

PURPOSE: This phase I trial is studying the side effects of curcumin in preventing colorectal cancer in patients undergoing colorectal endoscopy or colorectal surgery.

详细描述

OBJECTIVES:

Primary

  • To determine levels of curcumin and its metabolites in normal colorectal tissue in patients undergoing colorectal endoscopy or colorectal cancer surgery following a 14-day course of curcumin.

Secondary

  • To assess the practicality, acceptability, and safety of administering 5 capsules of curcumin daily for 14 days.
  • To check the presence of curcumin and its metabolites in peripheral blood and urine.

研究设计

研究类型
Interventional
主要目的
Prevention

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Concentration of curcumin in colorectal tissue after treatment

次要结局

  • Tolerability and compliance
  • Presence of curcumin and its metabolites in peripheral blood and urine

研究者

申办方类型
Other

研究点 (4)

Loading locations...

相似试验